Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 420 record(s)

Req # A-2023-000289

Adverse Drug Reaction (ADR). Report number: 001033517.

Organization: Health Canada

9 page(s)
June 2023

Req # A-2023-000311

Adverse Drug Reactions (ADRs). Report numbers: 001018620, 001018334, 001011335, 001015044, 001014046, 001010260, 001017628.

Organization: Health Canada

53 page(s)
June 2023

Req # A-2023-000316

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-101815-520, Exceptions for the Information Technology Community.

Organization: Health Canada

3 page(s)
June 2023

Req # A-2023-000329

Adverse Drug Reaction (ADR) for PMS-NITROFURANTOIN. Report number: 001025974.

Organization: Health Canada

5 page(s)
June 2023

Req # A-2023-000368

Adverse Drug Reaction (ADR) for RIVA-ARIPIPRAZOLE. Report number: 001038374.

Organization: Health Canada

2 page(s)
June 2023

Nothing to report this month

Organization: Canada Lands Company CLC Limited

June 2023

Req # CLC-A-2022-003

Please provide the total compensation (salary + benefits) paid out to executives for the calendar years 2019, 2020 and 2021. Include a breakdown of the different types of benefits paid out, including any performance or incentive pay received for each year. Please provide ranges if exact amounts cannot be provided. Search through electronic records only, unless relevant records do not exist in that format. Include documents in which cabinet material can be severed, however exclude documents marked cabinet confidences in their entirety. Remove French versions if English exists. Final version of documents or last draft if final version is not available

Organization: Canada Lands Company CLC Limited

2 page(s)
June 2022

Req # A-2022-000104

Obtain copies of all documents concerning the Company, including its capacity as tenant of the building located at: Company: Cozey Inc. NEQ: 1174955287. Building address: 5770 Ferrier St., Mont-Royal, QC H4P 1M7, Canada. Cadastre: 1 679 001. Owners: Summit Corporation Inc.

Organization: Health Canada

0 page(s)
June 2022

Req # A-2022-000242

All information pertaining to the Company or confirmation that the Company is in good standing with your organization. Company: Maturin 9374-1502 QUÉBEC INC. (NEQ: 1173467094) (BN: 714460714). Address: 201-125 Ste-Foy Blvd., Longueuil, QC J4J 1W7.

Organization: Health Canada

0 page(s)
June 2022

Req # A-2017-000370

All reviewers’ reports regarding the cleared New Drug Submission (NDS) for TECENTRIQ (atezolizumab), manufactured by Roche.

Organization: Health Canada

331 page(s)
June 2022
Date modified: